A Clinical Study of Ultrasound-guided Botulinum Toxin A Into Salivary Gland for Sialorrhea After True Bulbar Palsy
Latest Information Update: 01 Jul 2026
At a glance
- Drugs Botulinum Toxin A (Primary)
- Indications Sialorrhoea
- Focus Therapeutic Use
Most Recent Events
- 24 Jun 2026 Study design changed from randomized to non-randomized and double-blind to single blind.
- 24 Jun 2026 Status changed from recruiting to withdrawn prior to enrolment. Reason the study was stopped: In accordance with the time-limit regulations for ethical review, since the ethical approval certificate of this study protocol has expired, I hereby formally apply for the withdrawal of this study from the clinical trial registration platform.
- 24 Jun 2026 Planned End Date changed from 1 Sep 2025 to 1 Sep 2027.